Someone with a lot of money to spend has taken a bullish stance on Pfizer PFE.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with PFE, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 30 options trades for Pfizer.
This isn't normal.
The overall sentiment of these big-money traders is split between 63.33% bullish and 36.67%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $40,850.00, and 29, calls, for a total amount of $1,945,503.00..
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $37.0 to $60.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Pfizer's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale trades within a strike price range from $37.0 to $60.0 in the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| PFE | CALL | TRADE | BULLISH | 06/17/22 | $49.00 | $127.5K | 4.5K | 776 |
| PFE | CALL | TRADE | BULLISH | 06/17/22 | $49.00 | $127.5K | 4.5K | 426 |
| PFE | CALL | TRADE | BULLISH | 06/17/22 | $49.00 | $127.5K | 4.5K | 176 |
| PFE | CALL | TRADE | BEARISH | 06/17/22 | $49.00 | $126.9K | 4.5K | 3.8K |
| PFE | CALL | TRADE | BULLISH | 06/17/22 | $49.00 | $122.5K | 4.5K | 3.0K |
Where Is Pfizer Standing Right Now?
- With a volume of 7,365,546.00, the price of PFE is down -0.07% at $51.05.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 69 days.
What The Experts Say On Pfizer:
- BMO Capital downgraded its action to Outperform with a price target of $60.0
- SVB Leerink has decided to maintain their Market Perform rating on Pfizer, which currently sits at a price target of $48.0.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
